Home > Search: saquinavir mesylate

• Search Results

Search Results Get Your Free Credit Report Right Now! Zip Code: Join our discussion forums! Providers join our directory! General Topics A-Z Conditions Treatments Medications Fitness Nutrition Anatomy Travel/Destinations Other Topics From the West From the East

All Topic Areas 1 - 10 of 36  more >> Saquinavir Fortovase Invirase Gemifloxacin mesylate Factive Synephrine Somapractic Imatinib Gleevec imatinib mesylate News 1 - 5 of 19  more >> Pivotal Submission Data Shows Tasigna(R) Achieved Impressive Response Rates In Chronic Myeloid Leukemia Patients No Longer Helped By Gleevec(R) MedicalNewsToday - Tue, 26 Dec 2006 08:00 EST Interim Analysis Of New Study Suggests Boosted INVIRASE(R) May Achieve Similar Levels Of HIV Suppression To Boosted Lopinavir MedicalNewsToday - Tue, 14 Nov 2006 08:00 EST Gleevec(R) Demonstrates Highest Five-Year Overall Survival Rate In History Of Treatment For Patients With Chronic Myeloid Leukemia MedicalNewsToday - Thu, 07 Dec 2006 08:00 EST Ruboxistaurin Reduced Vision Loss In Patients With Moderate To Severe Non-Proliferative Diabetic Retinopathy In A New Study MedicalNewsToday - Tue, 14 Nov 2006 08:00 EST Roche To Transfer Technology For Protease Inhibitor Saquinavir To Three Generic Drug Companies In Sub-Saharan Africa MedicalNewsToday - Wed, 27 Sep 2006 02:00 EST Clinical Trials 1 - 5 of 339  more >> A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children ClinicalTrials.gov Identifier: NCT00000913 - Active, not recruiting HIV Infections A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients ClinicalTrials.gov Identifier: NCT00002378 - Completed HIV Infections A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination with Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients ClinicalTrials.gov Identifier: NCT00002178 - Completed HIV Infections A 48 week study looking at the effectiveness of giving saquinavir/ritonavir, twice daily plus emtricitabine/tenofovir, once daily compared to giving lopinavir/ritonavir twice daily plus emtricitabine/tenofovir once daily in HIV-1 patients not previously t ClinicalTrials.gov Identifier: NCT00105079 - Active, not recruiting HIV Infections Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma ClinicalTrials.gov Identifier: NCT00003008 - Active, not recruiting epidemic Kaposi's sarcoma; recurrent Kaposi's sarcoma

GoldBambooTM Your Integrative Health and Wellness Resource November 23, 2009

email this page   |    print this page   |    bookmark this page   |    feedback on this page Page Updated: January 17, 2009

Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.